Variation in the immune response to adenoviral vectors in the brain: influence of mouse strain, environmental conditions and priming
- 1 April 1999
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 6 (4) , 471-481
- https://doi.org/10.1038/sj.gt.3300851
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 66 references indexed in Scilit:
- Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expressionGene Therapy, 1997
- Persistent transgene expression in mouse liver following in vivo gene transfer with a ΔE1/ΔE4 adenovirus vectorGene Therapy, 1997
- Characterization of Factors Involved in Modulating Persistence of Transgene Expression from Recombinant Adenovirus in the Mouse LungHuman Gene Therapy, 1997
- Immune responses to adenovirus vectors in the nervous systemTrends in Neurosciences, 1996
- Transplantation tolerance induced by antigen pretreatment and depleting anti‐CD4 antibody depends on CD4+ T cell regulation during the induction phase of the responseEuropean Journal of Immunology, 1995
- Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosisNature Genetics, 1994
- The Dendritic Cell System and its Role in ImmunogenicityAnnual Review of Immunology, 1991
- Therapy with monoclonal antibodies by elimination of T-cell subsets in vivoNature, 1984
- DISTRIBUTION AND QUANTITATION OF HLA-ABC AND DR (Ia) ANTIGENS ON HUMAN KIDNEY AND OTHER TISSUESTransplantation, 1980
- Murine cytotoxic T-cell response to alphavirus is associated mainly withH- 2D kImmunogenetics, 1978